Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform. - Volkman, Hannah R.; de Munter, Leonie; Nguyen, Jennifer L.; Tran, Thao M. P.; Mitratza, Marianna; Marques, Cátia; Choi, Laura; Valluri, Srinivas; Yang, Jingyan; Antón, Andrés; Casas, Irma; Conde-Sousa, Eduardo; et al. (PLoS ONE, 2026)